Eyeonix AIQ 3Q 2026: Revenue $27.9K, EPS ($0.00) — 10-Q Summary

Eyeonix AIQ reported 3Q 2026 revenue of $27.9K, up 6.9% YoY, but swung to a loss due to higher operating expenses. Digital marketing sales increased, but the company expects continued losses and may need additional financing. According to the filing, expenses rose to $43.5K from $25.7K.

Original reporting
Published Nov 12, 2026, 6:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 6:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Eyeonix AIQ 3Q 2026: Revenue $27.9K, EPS ($0.00) — 10-Q Summary — source image
Decision brief

The 30-second read

Low
01

Why it matters

The filing provides the first public disclosure of the company's latest financial performance, indicating continued cash burn and a need for new financing.

02

Market read

Micro‑cap earnings release with limited broader market impact.

03

What to watch

Potential need for additional financing could dilute existing shareholders

Relevance 6/10Novelty 5/10Timing: after-hours release

Background

Eyeonix AIQ, Inc. filed its 10‑Q for Q3 2026 showing modest revenue growth but a swing to a loss and higher operating expenses.

Market effects

Limited impact on digital marketing sector due to small size

Minimal regional effect

Low

Counterpoint

The loss may be temporary as the company pivots to digital marketing

Key entities

  • Eyeonix AIQ, Inc.

    Digital marketing services provider reporting Q3 2026 results

Related articles

$NOKMed

LightCounting:: November 2026 Nokia SReXperts

Nokia hosted its SReXperts/Wavelengths conference in November 2026, focusing on AI's impact on connectivity and its solutions for customers. The company reported strong Q3 2026 earnings, with AI & Cloud sales doubling year-over-year and $1.7 billion in new orders. Nokia expects 25-30% growth in its Optical and IP Networks businesses in 2027. The company aims to help telecom operators adapt to AI-driven changes and capitalize on new opportunities.

$IBRXLow

IBRX Stock Eyes Best Year Ever: Founder Teases 12 Months Of ‘Stealth’ NantWorks Reveals — Cancer Tech, AI Chips And Satellites

ImmunityBio (IBRX) reported a 53% increase in Q3 net product revenue to $48.7M, with 92% growth for the first nine months. The company is testing its drug Anktiva for sepsis and aims to expand FDA approval for bladder cancer. NantWorks, led by Patrick Soon-Shiong, plans a blockchain-based exchange for tokenized securities. IBRX stock has risen 195% over the past year, with bullish retail sentiment on Stocktwits.

$MBGLHighAI 8/10

Why Mobility Global Stock Gained Today

Mobility Global (MBGL) shares rose 16% after reporting Q3 earnings. Revenue increased 7.4% to $478M, with CARFAX sales up 8% to $313M. EBITDA grew 2% to $195M, and EPS was $0.40, beating estimates. Free cash flow rose 37% to $186M, leading to an $800M buyback program and a $0.06 quarterly dividend. The company expects $1.88B in 2026 revenue and raised EBITDA guidance to $750M.